Galectin Therapeutics Inc (NASDAQ:GALT)

3.29
Delayed Data
As of Apr 24
 -0.04 / -1.20%
Today’s Change
3.00
Today|||52-Week Range
16.55
-5.19%
Year-to-Date
No recent news for Galectin Therapeutics Inc.

Today’s Trading

Previous close3.33
Today’s open3.35
Day’s range3.26 - 3.35
Volume46,261
Average volume (3 months)122,086
Market cap$77.7M
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+40.00%
Earnings growth (this year)+2.56%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
CGIXCancer Genetics Inc-0.05-0.49%
AVDXAvant Diagnostics In...0.000.00%
GBSNUGreat Basin Scientif...+2.20+13.92%
GBIMGlobeImmune Inc-0.23-2.73%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateMay 15, 2015
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$0.00
Annual profit (last year)-$16.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Director &
Chief Medical Officer
Peter G. Traber
Chief Operating Officer &
Secretary
Harold H. Shlevin
Corporate headquarters
Norcross, Georgia

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers